| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | See Remarks
3 companies
Venkatesan Jay is a Director at EXICURE, INC. with holdings across 3 companies. Recent SEC Form 4 filings include 11 buys and 1 sell.
Estimated insider holdings value: $2.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 25, 2022 | ELTX Elicio Therapeutics, Inc. | See Remarks | Buy | 11,313 | $1.25 | $14,102.79 | +0.6% | -19.8% | -32.5% | |
| May 24, 2022 | ELTX Elicio Therapeutics, Inc. | See Remarks | Buy | 82,200 | $1.23 | $101,428.00 | +2.5% | -17.9% | -33.3% | |
| Dec 28, 2021 | ELTX Elicio Therapeutics, Inc. | See Remarks | Buy | 277,244 | $2.63 | $730,373.17 | +9.9% | -17.0% | -67.6% | |
| Dec 20, 2021 | ELTX Elicio Therapeutics, Inc. | See Remarks | Buy | 3,527 | $2.54 | $8,975.86 | +0.3% | -17.6% | -68.1% | |
| Dec 17, 2021 | ELTX Elicio Therapeutics, Inc. | See Remarks | Buy | 41,625 | $2.55 | $105,951.18 | +1.6% | -12.5% | -66.7% | |
| Dec 15, 2021 | ELTX Elicio Therapeutics, Inc. | See Remarks | Buy | 77,604 | $2.41 | $186,955.80 | +6.3% | -29.3% | -66.3% | |
| Feb 9, 2021 | ELTX Elicio Therapeutics, Inc. | See Remarks | Sell | 159,177 | $16.00 | $2,546,832.00 | -11.6% | - | - | |
| Aug 2, 2019 | XCUR Exicure, Inc. | Director | Buy | 250,000 | $2.00 | $500,000.00 | +478.6% | - | - | |
| Sep 26, 2017 | XCUR Exicure, Inc. | Director | Buy | 66,666 | $3.00 | $199,998.00 | +73.9% | - | - |